Compagnie Generale des Etablissements Michelin SCA (0OFM)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 33.05 |
|---|---|
| 52-week range | 25.45 – 35.97 |
| Return, 1 month / 3 months | −0.2% / −5.9% |
| Return, 1 year / 3 years | +26.8% / +34.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 21.3% |
| Worst drawdown (1 year) | -17.7% |
| Average daily value traded | 12.38M EUR |
| Dividend yield | 4.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Compagnie Generale des Etablissements Michelin SCA is a French tyre maker based in Clermont-Ferrand. It designs and produces tyres for cars, vans, trucks, buses, motorcycles, aircraft, and agricultural and construction machinery, and it sells under brands such as Michelin, BFGoodrich and Kleber. Its customers include vehicle manufacturers, fleet operators and motorists, and it also runs retail and travel services, including maps and restaurant guides.
Compagnie Generale des Etablissements Michelin SCA trades under the code 0OFM on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Compagnie Generale des Etablissements Michelin SCA (0OFM) trades on the London Exchange in UK. It last closed at EUR 33.05 on 19 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 530 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.8% and over the last three months it fell 5.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.7% | ||
| From 52-week high | -6.2% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.9% | ||
| 6-month return | 8.2% | ||
| 12-month return, skipping the last month | 27.0% | ||
| Risk (lower is better) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 21.3% | ||
| Worst drawdown (1 year) | -17.7% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 12.38M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.2% | ||
| Years with dividends | 5 |
Strengths
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | −0.2% |
| 3 months | −5.9% |
| 6 months | +8.2% |
| 1 year | +26.8% |
| 3 years | +34.4% |
| 5 years | +21.8% |
Signals
| 50-day / 200-day average | 33.97 / 31.88 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2026 | EUR 1.3800 |
| 21 May 2025 | EUR 1.3800 |
| 22 May 2024 | EUR 1.3500 |
| 17 May 2023 | EUR 1.2500 |
| 17 May 2022 | EUR 4.5000 |
| 25 May 2021 | EUR 2.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.